Jonathan Jude Perera (Jonathan Perera)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Mesenchymal Stem Cells

Cognitive Decline

Multiple Sclerosis

Top Venues

Clinical and translational medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Rawan Al-Kharboosh, Jonathan Jude Perera, Alexandra Bechtle, Guojun Bu, Alfredo Quinones-Hinojosa
Emerging point-of-care autologous cellular therapy using adipose-derived stromal vascular fraction for neurodegenerative diseases. Clinical and translational medicine 12 (12) (2022)
Rawan Al-Kharboosh, Jonathan Jude Perera, Alexandra Bechtle, Guojun Bu, Alfredo Quinones-Hinojosa
Emerging point-of-care autologous cellular therapy using adipose-derived stromal vascular fraction for neurodegenerative diseases. Clinical and translational medicine 12 (12) (2022)
William H Tomaszewski, Jessica Waibl-Polania, Molly A Chakraborty, Jonathan Jude Perera, Jeremy J Ratiu, Alexandra M Miggelbrink, Donald P McDonnell, Mustafa Khasraw, David M Ashley, Peter E Fecci, Luigi Racioppi, Luis Sanchez-Perez, Michael Dee Gunn, John H Sampson
Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma. Nature communications 13 (1) (2022)
Rawan Al-Kharboosh, Jonathan Jude Perera, Alexandra Bechtle, Guojun Bu, Alfredo Quinones-Hinojosa
Emerging point-of-care autologous cellular therapy using adipose-derived stromal vascular fraction for neurodegenerative diseases. Clinical and translational medicine 12 (12) (2022)
Rawan Al-Kharboosh, Jonathan Jude Perera, Alexandra Bechtle, Guojun Bu, Alfredo Quinones-Hinojosa
Emerging point-of-care autologous cellular therapy using adipose-derived stromal vascular fraction for neurodegenerative diseases. Clinical and translational medicine 12 (12) (2022)